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Abstract Key enzymes of the glyoxylate cycle, isocitrate lyase
(ICL) and malate synthase (MS), have been detected in the liver
of alloxan-treated rats. The activity of ICL in rat liver was 0.040
Wmol/min/mg protein and the activity of MS was 0.022 Wmol/
min/mg protein. These enzymes were associated with the
peroxisomal fraction. The activities of citrate synthase, malate
synthase and malate dehydrogenase detected in the peroxisomal
fraction were also increased by alloxan treatment. Isocitrate
lyase was partially purified and displayed catalytic and
regulatory properties similar to those of the enzyme isolated
from the liver of starved rats (Popov, V.N. et al. (1996) FEBS
Lett. 391, 87^90).
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1. Introduction
Glyoxylate cycle (GC) enzymes have been found in the
larvae of lower invertebrates, where this cycle facilitates the
utilization of stored fats for gluconeogenesis during growth
[1,2]. Some data pointing to the possibility of glyoxylate cycle
operation have also been published for vertebrates [3,4]. We
have shown previously that key enzymes of the glyoxylate
cycle, isocitrate lyase (ICL) and malate synthase (MS) can
be detected in liver extracts of starved rats. We have deter-
mined the activities of these enzymes, puri¢ed and character-
ized them. These data established the existence of these key
enzymes of the glyoxylate cycle in mammalian tissue [5,6]. It
has provided the biochemical basis for the physiological phe-
nomena of de novo glycogen synthesis in rat liver upon star-
vation [7,8]. The time course of isocitrate lyase and malate
synthase induction correlated perfectly with the kinetics of
glycogen synthesis, and the mechanism of this synthesis may
now be discussed in terms of carbon £ow from acetyl-CoA.
We suggested that in mammalian tissue an increase in glyco-
gen synthesis upon food starvation from acetyl-CoA could be
due to the glyoxylate cycle, similar to carbohydrate synthesis
in bacterial or plant cells.
The glyoxylate cycle was originally discovered by Kornberg
and Krebs in bacteria grown on acetate [9]. The cycle couples
the metabolism of two-carbon compounds to gluconeogenesis.
Malate synthase and isocitrate lyase were recognized as path-
way-speci¢c enzymes, while the other enzymes involved were
in common with the mitochondrial TCA cycle. Later, the
glyoxylate cycle was also detected in germinating seeds of
plants [10]. It was shown to involve its own speci¢c enzyme
complement in the isolated glyoxysomes in addition to en-
zymes catalyzing fatty acid L-oxidation.
Subsequently, di¡erent types of microbodies were discov-
ered in plant tissue. One of these types, named glyoxysomes,
containing the enzymes of the glyoxylate cycle and of the L-
oxidation pathway, was detected in germinating fat-storing
seeds [11]. Induction of the glyoxylate cycle by starvation is
associated with the degradation of liver tissue, and it is an
extreme physiological process. Participation of this pathway
in fatty acids to carbohydrate conversion may be related to
other situations, which are associated with the mobilization of
fatty acids. One such physiologically occurring process is dia-
betes, which causes a decrease in carbohydrate concentration
paralleled by intensive mobilization of fats [12]. Glycogen for-
mation in the diabetic liver utilizing fatty acids as a source of
carbon skeleton synthesis has also been shown [8]. Using the
same experimental model of alloxan-induced diabetes, we in-
vestigated the possibility of induction of the glyoxylate cycle
enzymes under these conditions. We report here the induction
of glyoxylate cycle enzymes by alloxan treatment and describe
the subcellular location of these enzymes, as well as some
catalytic properties of the key enzyme of the cycle, isocitrate
lyase.
2. Materials and methods
Three months old rats (Rattus rattus L.) fed with standard rat chow
were injected with alloxan (200 mg per kg of weight in 0.9% NaCl
solution). Control animals were treated with the isotonic NaCl solu-
tion. Induction of diabetes was monitored by measuring the glucose
concentration in blood. In the control group the glucose concentra-
tion was 8.3 þ 1.1 mM. Alloxan injection induced an increase in blood
glucose up to 18.7 þ 2.0 mM, seven days after injection.
Animals were anesthetized with ethyl ester and decapitated. The
liver was excised and weighed, then 1 g of liver tissue was homogen-
ized in 10 ml of 50 mM Tris-HCl, pH 7.5, 1 mM MgCl2, 1 mM
dithiothreitol, 1 mM EDTA and 0.1% Triton X-100. The homogenate
was centrifuged at 4000Ug for 5 min. The supernatant was used for
enzyme analysis. When the supernatant was used for the preliminary
isolation of organelles, Triton X-100 was omitted and 0.3 M sucrose
was added to the medium. For organelle isolation, the supernatant
was applied on top of a continuous sucrose gradient (25^57%) buf-
fered with 50 mM Tris-HCl, containing 1 mM MgCl2, 1 mM dithio-
threitol and 0.5 mM EGTA. It was centrifuged to equilibrium for 2.5
h at 100 000Ug max. Two-ml fractions were collected, diluted up to
0.25 mM sucrose concentration and centrifuged 15 min at 20 000Ug
max. The pellet was resuspended in 50 mM Tris-HCl bu¡er, contain-
ing 1 mM dithiothreitol, 1 mM MgCl2 and 0.1% Triton X-100, and
used for detection of enzyme activities.
Enzyme assays were performed at 25‡C. Isocitrate lyase activity was
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measured using the method of Dixon and Kornberg [13]. The assay
mixture of 1 ml consisted of 50 mM Tris-HCl, pH 7.5, 2 mM iso-
citrate, 5 mM MgCl2 and 4 mM phenylhydrazine-HCl. The reaction
was followed spectrophotometrically at 324 nm. An extinction coef-
¢cient of 1.67U104 M31 cm31 was used. Malate synthase activity was
measured according to Hock and Beevers [14]. The assay mixture
consisted of 50 mM Tris-HCl, pH 7.6, 0.15 mM acetyl-CoA, 2 mM
glyoxylate, and 1 mM 5,5P-dithio-bis(2-nitrobenzoic acid). The activity
was measured at 412 nm using an extinction coe⁄cient of 1.36U104
M31 cm31. Catalase activity was determined according to Breiden-
bach et al. [15], and the activity of succinate dehydrogenase, fumarase
and alcohol dehydrogenase according to Cooper and Beevers [16], and
one unit (E.U.) of activity was de¢ned as the conversion of 1 Wmol of
a substrate per min. Protein was measured according to Lowry et al.
[17].
Isocitrate lyase was puri¢ed by the following procedure. Proteins of
a crude extract (10 ml) were precipitated by ammonium sulfate (50^
70% saturation), maintaining pH 7.5 by adding 0.1 M NaOH. Pro-
teins were dissolved and desalted on a Sephadex G-25 column (15U1
cm). A test with Nessler reagent was used to control the complete
removal of ammonium sulfate. Proteins were applied to a DEAE-
cellulose 52 (Whatman, UK) column (20U2 cm) equilibrated with
10 mM Tris-HCl. Proteins were eluted by a step gradient, eluting ¢rst
with 20 ml of 30 mM KCl and then with 40 mM KCl in column
bu¡er. Fractions with isocitrate lyase activity were collected, dialyzed
against the column bu¡er and applied to a Toyopearl HW-65 (Toyo-
Soda, Japan) column (90U2 cm) equilibrated with 25 mM Tris-HCl
bu¡er, pH 7.5, containing 3 mM MgCl2, 1 mM EDTA and 3 mM
dithiothreitol. Elution was performed with the same bu¡er, and frac-
tions containing isocitrate lyase activity were used for enzyme char-
acterization.
3. Results
No isocitrate lyase or malate synthase activity was detected
in crude extracts of livers isolated from non-treated animals.
Injection of alloxan induced both ICL and MS activities.
These activities became measurable in the liver of rats having
a blood glucose concentration greater than 15 mM, i.e. with
developed diabetes. The activities were detectable from 7 to 30
days after injection. Seven days after alloxan injection the
speci¢c activity of isocitrate lyase in crude extracts of liver
tissue was 0.040, and of malate synthase 0.022 Wmol/min/mg
protein (Fig. 1). Determination of these enzymes in other
tissues has shown that ICL and MS activities were present
in rat kidney (Table 1). Determination of malate dehydrogen-
ase, citrate synthase and aconitate hydratase activities also
revealed their increase in livers of alloxan-treated rats (Fig.
1). Thus, the activity of glyoxylate cycle enzymes was detected
only in the liver of rats with alloxan diabetes.
To determine the intracellular localization of isocitrate lyase
in rat liver tissue, an isopycnic centrifugation of a crude or-
ganelle extract (the supernatant after centrifugation at
4000Ug for 5 min) was performed. Catalase served as a
marker for peroxisomes, succinate dehydrogenase and fumar-
ase served as markers for mitochondria, and lactate dehydro-
genase was a marker for the cytosolic fraction. Isocitrate lyase
and malate synthase activities were con¢ned to the fraction
where the maximal catalase activity was revealed, i.e. to the
fraction of specialized peroxisome-like organelles (Table 2).
About 35% of total activity of ICL and MS was detected in
the cytosol, but it corresponds to the same amount of catalase
solubilized from ruptured microbodies. Therefore it has to be
supposed that isocitrate lyase and malate synthase activities
are located in the peroxisomal fraction. Increasing activities of
malate dehydrogenase (MDH), citrate synthase (CS) and aco-
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Fig. 1. Induction of glyoxylate cycle enzymes activities (Wmol/min/
mg protein) in liver of alloxan-treated rats. A: Control animals
(0.9% NaCl injection). B: Seven days after alloxan injection (200 mg
per kg weight); 1, isocitrate lyase; 2, malate synthase; 3, malate de-
hydrogenase; 4, citrate synthase; 5, aconitate hydratase.
Table 1
Tissue speci¢city of glyoxylate cycle key enzymes in rat (7 days after alloxan injection, 200 mg per kg rat weight), Wmol/min/g fresh weight
Liver Heart Muscle Kidney Blood Brain
Isocitrate lyase 2.6 No No 0.94 No No
Malate synthase 1.4 No No 0.60 No No
Table 2
Subcellular location of glyoxylate cycle enzymes (Wmol/min) in control and alloxan-treated rats (7 days after injection of 200 mg/kg weight of
alloxan)
Control Alloxan diabetes
Cytosol Mitochondria Peroxisomes Cytosol Mitochondria Peroxisomes
ICL 0 0 0 0.136 0.072 0.325
MS 0 0 0 0.091 0.041 0.124
CS 0.08 0.125 0.025 0.131 0.200 0.190
MDH 0.12 0.185 0.029 0.182 0.245 0.200
AH 0.052 0.08 0.018 0.085 0.060 0.181
Protein (mg) 6.45 5.51 3.24 6.57 5.7 3.4
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nitate hydratase (AH) were also connected with the peroxiso-
mal fraction. Whereas MDH, CS and AH activities were in-
creased in the cytosol and mitochondrial fractions by only
1.2^2.0-fold, the activities in microbodies increased 7^10-fold.
For preliminary enzyme characterization, isocitrate lyase
was puri¢ed 108.7-fold by ammonium sulfate precipitation,
ion-exchange chromatography on DEAE-cellulose and gel-
chromatography on Toyopearl HW-65 (Table 3). The speci¢c
activity of the puri¢ed enzyme was 8.7 Wmol/min/mg protein.
Rat liver isocitrate lyase showed a Michaelis kinetics with a
Km (isocitrate) = 68 WM and a pronounced pH optimum at pH
7.4^7.6 (Fig. 2).
The regulatory properties of ICL from liver of alloxan-
treated rats were studied using the method of Dixon [18]. It
was shown that glucose-6-phosphate and glucose-1-phosphate
are the competitive inhibitors of ICL with Ki of 1.25 and 1.6
mM, respectively. Citrate inhibits ICL with a Ki of 0.95 mM;
an inhibition of isocitrate lyase by the reaction product, suc-
cinate, was discovered (Ki=1.75 mM).
4. Discussion
In this study the presence of key enzymes of the glyoxylate
cycle, isocitrate lyase and malate synthase, was found in liver
extracts of alloxan-treated rats. Induction of these enzymes
correlated with the increase of glucose concentration in blood,
i.e. with the induction of alloxan diabetes. The increase in
activities of other glyoxylate cycle enzymes was also detected.
Thus, we can conclude that alloxan diabetes causes the induc-
tion of complete glyoxylate cycle. The possible role of glyoxy-
late metabolic pathway in diabetic rats may be related to
mobilization of fatty acids. The discovery in 1976 by Lazarow
and De Duve of the peroxisomal L-oxidation of fatty acids in
rats substantiates the possibility of acetyl-CoA formation in
these organelles [19]. Operation of the glyoxylate cycle in per-
oxisomes would result in e⁄cient succinate production which
in turn can fuel gluconeogenesis in the rat liver. The micro-
bodial localization of isocitrate lyase and malate synthase in
rat liver is not surprising because glyoxylate cycle enzymes
have often been detected in specialized microbodies (glyoxy-
somes) [11], and indications on di¡erent localization are rare
[20].
It should be emphasized that we detected the rise in activ-
ities of all glyoxylate cycle enzymes recovered in the peroxi-
somal fraction. The presence of a complete glyoxylate cycle in
peroxisomes would liberate acetyl-CoA formation and utiliza-
tion from mitochondrial control.
We have shown earlier that the glyoxylate cycle is induced
in the liver of starved rats [5,6]. The properties of puri¢ed
enzymes isolated from the liver of alloxan-treated rats corre-
sponded to previously published data for isocitrate lyase iso-
lated from the liver of starved rats. These enzymes have sim-
ilar speci¢c activities, catalytic and regulatory properties.
However, inhibition by citrate and succinate was not reported
earlier. This may be related to the physiological signi¢cance of
this phenomenon, since mobilization of fatty acids is neces-
sary for supporting the energy balance and carbohydrate level
during diabetes, and to the regulation of further metabolism
of succinate.
Diabetes and starvation usually cause a rise in fatty acid
concentration in blood and liver tissues [21]. This fact may be
related to the mechanism of glyoxylate cycle induction
through the operation of a peroxisome proliferator-activated
receptor (PPAR). Activation of this receptor causes the ex-
pression of key enzymes of fatty acid metabolism [22] and it is
possible that GC expression is regulated by a similar mecha-
nism. It is interesting to note that Wilson and coauthors [23]
showed one of the antidiabetics, thiazolidinedione, to in£u-
ence PPAR and to activate peroxisomal proliferation.
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Table 3
Puri¢cation of isocitrate lyase from liver of alloxan-treated rats
Puri¢cation step Total activity
(Wmol/min)
Total protein
(mg)
Speci¢c activity
(Wmol/min/mg protein)
Yield
(%)
Puri¢cation factor
(-fold)
Crude extract 20.5 260.0 0.08 100 1
Ammonium sulfate fractionation
(50^70% of saturation)
12.3 54.6 0.23 60.0 2.8
DEAE-Toyopearl 6.7 2.5 2.68 32.6 33.5
Toyopearl HW-65 3.1 0.35 8.70 15.1 108.7
Fig. 2. pH dependence of isocitrate lyase activity from liver of allox-
an-treated rats. 1, Tris-HCl, 50 mM; 2, Na2HPO4/NaH2PO4, 50
mM; 3, Tris-HEPES, 20 mM.
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